Share this @internewscast.com

The NHS is giving up to 150,000 patients an artificial pancreas in what has been hailed a ‘landmark moment’ for type 1 diabetics.

The world-first rollout will effectively spell the end of painful finger prick blood tests and regular injections for most people with the condition.

The device – known as a hybrid closed-loop system – uses a hi-tech algorithm to determine the amount of insulin needed to keep the wearer’s blood sugar levels steady, which is delivered via a pump.

Experts say the ‘futuristic technology’ will transform lives of those with the condition after trials found it more effective at managing the condition than current devices, while needing far less input from patients.

An artificial pancreas to manage type 1 diabetes could soon be offered to NHS patients after a major trial produced 'blisteringly brilliant' early results. The high-tech kit continuously monitors glucose levels via sensors under a patient's skin and, when needed, automatically delivers insulin to the bloodstream ¿ a job normally carried out in the body by the pancreas

An artificial pancreas to manage type 1 diabetes could soon be offered to NHS patients after a major trial produced ‘blisteringly brilliant’ early results. The high-tech kit continuously monitors glucose levels via sensors under a patient’s skin and, when needed, automatically delivers insulin to the bloodstream – a job normally carried out in the body by the pancreas

NHS England has given £2.5million to local health authorities to start identifying patients who will benefit during the five-year programme.

Diabetes charities said it was ‘incredibly exciting’ for patients.

Colette Marshall, Chief Executive of Diabetes UK, said: ‘Diabetes is a tough and relentless condition, but these systems make a significant, life-changing difference – improving both the overall health and quality of life for people with diabetes.

‘This really is a landmark moment and we’ll be working with the NHS and others to ensure a fair rollout that reaches people as quickly as possible.’

How does the ‘artificial pancreas’ work?

The technology – which costs less than £5,000 per patient – uses a ‘hybrid closed-loop system’ sensor to continually monitor blood glucose.

The sensor wirelessly transmits readings to the high-tech insulin pump which runs a mathematical calculation to work out how much insulin needs to be delivered at a time into the body to keep blood glucose levels within a healthy range.

The body worn insulin pump then automatically delivers insulin into the bloodstream.

Type 1 diabetes is when the pancreas makes either no or insufficient insulin, causing potentially fatal high blood sugar levels.

It can be especially difficult to manage in children due to variations in the levels of insulin required and unpredictability around how much patients eat and exercise.

The device is worn next to the body to continually monitor blood glucose levels and automatically adjusts insulin which is delivered via a pump.

Last year, the National Institute of Health and Care Excellence (Nice) recommended offering the wearable device to those with diabetes not adequately controlled by their current pump or glucose monitor.

It agreed with NHS England that all children and young people, women who are pregnant or planning a pregnancy, and those people who already have an insulin pump will be first to be offered a hybrid closed loop system, with around 152,000 eligible overall.

Professor Partha Kar, NHS national speciality advisor for diabetes, said: ‘The national roll out of Hybrid Closed Loop systems is great news for everyone with type 1 diabetes.

‘The device detects your glucose levels, transmits the readings to the delivery system, known as the pump, which then initiates the process of determining the required insulin dosage.

‘This futuristic technology not only improves medical care but also enhances the quality of life for those affected.’

Share this @internewscast.com
You May Also Like

Can Heartbreak Lead to a Brain Aneurysm? Experts Discuss Following Kim Kardashian’s Diagnosis

Kim Kardashian recently amazed her followers by disclosing a surprising health scare—a…

Understanding Charcot-Marie-Tooth: The Rare Disease Behind the Tragic Loss of 9-1-1 Nashville’s Isabelle Tate

The young actress from 9-1-1 Nashville, who passed away at the age…

Revolutionary Robotic Surgery: Hospital Achieves Record 12 Prostate Operations in One Day Amid Rising NHS Wait Times

In a remarkable stride towards alleviating the protracted NHS waiting lists, a…

After Spending £1,700 on Ozempic, I Gained Weight – Here’s What You Need to Know

A woman has shared her experience of spending over £1,700 on a…

Uncover the Alarming New Symptom of the Latest COVID Variant: What You Need to Know

The National Health Service (NHS) is urging residents in the UK to…

Discover the 15-Minute Pharmacist-Approved Method to Relieve Heartburn Permanently

Dealing with heartburn can be challenging, but a simple routine might just…

Breaking Free After 20 Years: The Bold Tinnitus Treatment Doctors Won’t Tell You About

Ayahuasca, a potent hallucinogenic brew, has become a popular remedy among wellness…

How a Break-Up Transformed My Life: From Size 22 to Size 6

A remarkable transformation story has emerged as a woman from Essex reveals…

Skipping This Daily Ritual Could Skyrocket Your Stroke Risk – It’s Not Exercise!

Adopting a healthier lifestyle by incorporating regular exercise, quitting smoking, and maintaining…

Why Cholera Still Persists: Insights from Hakainde Hichilema and Tedros Adhanom Ghebreyesus

The United Kingdom last experienced a cholera outbreak in 1866, while the…

Former ‘Biggest Loser’ Contestants Share Secrets to Long-Term Weight Loss Success Without Ozempic

Half a decade after the curtain fell on The Biggest Loser’s final…